27
Views
3
CrossRef citations to date
0
Altmetric
Case Reports

Sarcoidosis: case report and review

, MScOptom MBBS PhD, , BMedSci MBBS, , BMedSci MBBS, , MD FRANZCO FRACS & , BScOptom PhD PGDipAdvClinOptom FVCO FAAO FCLSA
Pages 361-367 | Received 21 Aug 2006, Published online: 15 Apr 2021

REFERENCES

  • Baughman RP, Lower EE, Du bois RM. Sarcoidosis. Lancet 2003; 361: 1111–1118.
  • Haslet C, Chilvers ER, Corris PA. Respiratory disease. In: Haslet C, Chilvers ER, Boon NA, Colledge NR, eds. Davidson’s Principles and Practice of Medicine, 19th ed. London: Churchill Livingstone, 2002. p 483–574.
  • Siltzbach LE, James DG, Neville E, Turiaf J, Battesti JP, Sharma OP, Hosoda Y, Mikami P, Odaka M. Course and prognosis of sarcoidosis around the world. Am J Med 1974; 57: 847–852.
  • Jones NP. Sarcoidosis and uveitis. Ophthalmol Clin North Am 2002; 15: 319–326.
  • Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med 1997; 336: 1224–1234.
  • King TE. Overview of sarcoidosis, 2005. available online http://www.uptodate.com.
  • Verleden GM, Du bois RM, Bouros D, Drent M, Millar A, Muller‐quernheim J, Semenzato G, Johnson S, Sourvino G, Oliver D, Pietinalho A, Xaubet A. Genetic predisposition and pathogenetic mechanisms of interstitial lung diseases of unknown origin. Eur Respir J 2001; 32 Suppl: 17s–29s.
  • Nunes H, Soler P, Valeyre D. Pulmonary sarcoidosis. Allergy 2005; 60: 565–582.
  • Hart LA, Conron M, Du bois RM. Sarcoidosis. Int J Tuberc Lung Dis 2001; 5: 791–806.
  • Wu JJ, Schiff KR. Sarcoidosis. Am Fam Physician 2004; 70: 312–322.
  • Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999; 160: 736–755.
  • Costabel U. Sarcoidosis: clinical update. Eur Respir J 2001; 32 Suppl: 56s–68s.
  • Bonfioli AA, Orefice F. Sarcoidosis. Semin Ophthalmol 2005; 20: 177–182.
  • Izumo M, Sekiya K, Sakai T, Tojima H. A male case of acute sarcoidosis with fever, polyarthralgia, erythema nodosum, and bilateral hilar lymphadenopathy: Lofgren’s syndrome. Nihon Kokyuki Gakkai Zasshi 2005; 43: 761–765.
  • Handbook of Ocular Disease Management: Jobson Publishing, 2001. available online http://www.revoptom.com.
  • Bonfioli AA, Damico FM, Curi AL, Orefice F. Intermediate uveitis. Semin Ophthalmol 2005; 20: 147–154.
  • Lobo A, Barton K, Minassian D, Du bois RM, Lightman S. Visual loss in sarcoid‐related uveitis. Clin Experiment Ophthalmol 2003; 31: 310–316.
  • Yanardag H, Pamuk ON. Lacrimal gland involvement in sarcoidosis. The clinical features of 9 patients. Swiss Med Wkly 2003; 133: 388–391.
  • Shaikh ZA, Bakshi R, Greenberg SJ, Fine EJ, Shatla A, Lincoff NS. Orbital involvement as the initial manifestation of sarcoidosis: magnetic resonance imaging findings. J Neuroimaging 2000; 10: 180–183.
  • Judson MA, Thompson BW, Rabin DL, Steimel J, Knattereud GL, Lackland DT, Rose C, Rand CS, Baughmann RP, Teirstein AS, Access Research group. The diagnostic pathway to sarcoidosis. Chest 2003; 123: 406–412.
  • Heuser K, Kerty E. Neuro‐ophthalmological findings in sarcoidosis. Acta Ophthalmol Scand 2004; 82: 723–729.
  • Pietinalho A, Tukiainen P, Haahtela T, Persson T, Selroos O. Early treatment of stage II sarcoidosis improves 5‐year pulmonary function. Chest 2002; 121: 24–31.
  • Weisinger HS, Pesudovs K, Collin HB. Management of patients undergoing hydroxychloroquine (Plaquenil) therapy. Clin Exp Optom 2000; 83: 32–36.
  • Conron M, Beynon HL. Ketoconazole for the treatment of refractory hypercalcemic sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2000; 17: 277–280.
  • Thatayatikom A, Thatayatikom S, White AJ. Infliximab treatment for severe granulomatous disease in common variable immunodeficiency: a case report and review of the literature. Ann Allergy Asthma Immunol 2005; 95: 293–300.
  • Yoshikawa K, Kotake S, Ichiishi A, Sasamoto Y, Kosaka S, Matsuda H. Posterior sub‐Tenon injections of repository corticosteroids in uveitis patients with cystoid macular edema. Jpn J Ophthalmol 1995; 39: 71–76.
  • Sonoda KH, Enaida H, Ueno A, Nakamura T, Kawano YI, Kubota T, Sakamoto T, Ishibashi T. Pars plana vitrectomy assisted by triamcinolone acetonide for refractory uveitis: a case series study. Br J Ophthalmol 2003; 87: 1010–1014.
  • Benitez‐del‐castillo JM, Martinez‐de‐la‐casa JM, Pato‐cour E, Mendez‐fernandez R, Lopez‐abad C, Matilla M, Garcia‐sanchez J. Long‐term treatment of refractory posterior uveitis with anti‐TNFalpha (infliximab). Eye 2005; 19: 841–845.
  • Jones NP. Sarcoidosis. Curr Opin Ophthalmol 2002; 13: 393–396.
  • Baughman RP, Lower EE, Bradley DA, Raymond LA, Kaufman A. Etanercept for refractory ocular sarcoidosis: results of a double‐blind randomized trial. Chest 2005; 128: 1062–1047.
  • Cheung CM, Durrani OM, Stavrou P. Peripapillary choroidal neovascularisation in sarcoidosis. Ocul Immunol Inflamm 2002; 10: 69–73.
  • Kiryu J, Kita M, Tanabe T, Yamashiro K, Miyamoto N, Ieki Y. Pars plana vitrectomy for cystoid macular edema secondary to sarcoid uveitis. Ophthalmology 2001; 108: 1140–1144.
  • Uthman IW, Bizri AR, Shabb NS, Khury MY, Khalifeh MJ. Peritoneal sarcoidosis: case report and review of the literature. Semin Arthritis Rheum 1999; 28: 351–354.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.